Loading…

Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study

Background COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and a...

Full description

Saved in:
Bibliographic Details
Published in:Neurological sciences 2022-06, Vol.43 (6), p.3489-3496
Main Authors: Özdemir, Hüseyin Nezih, Dere, Birgül, Gökçay, Figen, Gökçay, Ahmet
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3
cites cdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3
container_end_page 3496
container_issue 6
container_start_page 3489
container_title Neurological sciences
container_volume 43
creator Özdemir, Hüseyin Nezih
Dere, Birgül
Gökçay, Figen
Gökçay, Ahmet
description Background COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE. Methods This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events. Results We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination ( p  = 0.46). Conclusions The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.
doi_str_mv 10.1007/s10072-022-05956-6
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8882374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2666705635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</originalsourceid><addsrcrecordid>eNp9UclOwzAQtRCIpfADHJAlzgFvsZMLqCqrVKkX4Go5zoSmCnGw06L-PYaU7cJhPJbmzZt58xA6puSMEqLOw8fLEsJipHkqE7mF9mmak4QLlW1v_jRTYg8dhLAghFBB-S7a4yljQhGxj6ZjD3gye7q_SmiOV8bauoWAg6kAV87jDlzXAH6r-zmGrm6gC-tLPMbWuxCSALavXWsaHPpluT5EO5VpAhxt8gg93lw_TO6S6ez2fjKeJlYo0SdU8LxUWVUIyLNUGJtnVU6jlDxVhShKAA6sZHF5WhBuGRemskyBVKW0Ego-QhcDb7csXqC00PbeNLrz9Yvxa-1Mrf9W2nqun91KZ1nGuBKR4HRD4N3rEkKvF27po46gmZRSkVTyNKLYgPoU66H6nkCJ_ri9HhzQ0QH96YCWsenk927fLV8njwA-AEIstc_gf2b_Q_sOlIeQ5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2666705635</pqid></control><display><type>article</type><title>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</title><source>Springer Nature</source><creator>Özdemir, Hüseyin Nezih ; Dere, Birgül ; Gökçay, Figen ; Gökçay, Ahmet</creator><creatorcontrib>Özdemir, Hüseyin Nezih ; Dere, Birgül ; Gökçay, Figen ; Gökçay, Ahmet</creatorcontrib><description>Background COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE. Methods This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events. Results We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination ( p  = 0.46). Conclusions The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.</description><identifier>ISSN: 1590-1874</identifier><identifier>EISSN: 1590-3478</identifier><identifier>DOI: 10.1007/s10072-022-05956-6</identifier><identifier>PMID: 35224704</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adverse events ; Convulsions &amp; seizures ; Coronaviruses ; Covid-19 ; COVID-19 - prevention &amp; control ; COVID-19 vaccines ; COVID-19 Vaccines - adverse effects ; Cross-Sectional Studies ; Epilepsy ; Humans ; Immunization ; Medicine ; Medicine &amp; Public Health ; Neurology ; Neuroradiology ; Neurosciences ; Neurosurgery ; Pandemics ; Patients ; Psychiatry ; SARS-CoV-2 ; Seizures ; Seizures - epidemiology ; Vaccines</subject><ispartof>Neurological sciences, 2022-06, Vol.43 (6), p.3489-3496</ispartof><rights>Fondazione Società Italiana di Neurologia 2022</rights><rights>2022. Fondazione Società Italiana di Neurologia.</rights><rights>Fondazione Società Italiana di Neurologia 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</citedby><cites>FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</cites><orcidid>0000-0002-0651-7276</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35224704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özdemir, Hüseyin Nezih</creatorcontrib><creatorcontrib>Dere, Birgül</creatorcontrib><creatorcontrib>Gökçay, Figen</creatorcontrib><creatorcontrib>Gökçay, Ahmet</creatorcontrib><title>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</title><title>Neurological sciences</title><addtitle>Neurol Sci</addtitle><addtitle>Neurol Sci</addtitle><description>Background COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE. Methods This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events. Results We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination ( p  = 0.46). Conclusions The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.</description><subject>Adverse events</subject><subject>Convulsions &amp; seizures</subject><subject>Coronaviruses</subject><subject>Covid-19</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - adverse effects</subject><subject>Cross-Sectional Studies</subject><subject>Epilepsy</subject><subject>Humans</subject><subject>Immunization</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Psychiatry</subject><subject>SARS-CoV-2</subject><subject>Seizures</subject><subject>Seizures - epidemiology</subject><subject>Vaccines</subject><issn>1590-1874</issn><issn>1590-3478</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UclOwzAQtRCIpfADHJAlzgFvsZMLqCqrVKkX4Go5zoSmCnGw06L-PYaU7cJhPJbmzZt58xA6puSMEqLOw8fLEsJipHkqE7mF9mmak4QLlW1v_jRTYg8dhLAghFBB-S7a4yljQhGxj6ZjD3gye7q_SmiOV8bauoWAg6kAV87jDlzXAH6r-zmGrm6gC-tLPMbWuxCSALavXWsaHPpluT5EO5VpAhxt8gg93lw_TO6S6ez2fjKeJlYo0SdU8LxUWVUIyLNUGJtnVU6jlDxVhShKAA6sZHF5WhBuGRemskyBVKW0Ego-QhcDb7csXqC00PbeNLrz9Yvxa-1Mrf9W2nqun91KZ1nGuBKR4HRD4N3rEkKvF27po46gmZRSkVTyNKLYgPoU66H6nkCJ_ri9HhzQ0QH96YCWsenk927fLV8njwA-AEIstc_gf2b_Q_sOlIeQ5g</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Özdemir, Hüseyin Nezih</creator><creator>Dere, Birgül</creator><creator>Gökçay, Figen</creator><creator>Gökçay, Ahmet</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0651-7276</orcidid></search><sort><creationdate>20220601</creationdate><title>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</title><author>Özdemir, Hüseyin Nezih ; Dere, Birgül ; Gökçay, Figen ; Gökçay, Ahmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adverse events</topic><topic>Convulsions &amp; seizures</topic><topic>Coronaviruses</topic><topic>Covid-19</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - adverse effects</topic><topic>Cross-Sectional Studies</topic><topic>Epilepsy</topic><topic>Humans</topic><topic>Immunization</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Psychiatry</topic><topic>SARS-CoV-2</topic><topic>Seizures</topic><topic>Seizures - epidemiology</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özdemir, Hüseyin Nezih</creatorcontrib><creatorcontrib>Dere, Birgül</creatorcontrib><creatorcontrib>Gökçay, Figen</creatorcontrib><creatorcontrib>Gökçay, Ahmet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özdemir, Hüseyin Nezih</au><au>Dere, Birgül</au><au>Gökçay, Figen</au><au>Gökçay, Ahmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</atitle><jtitle>Neurological sciences</jtitle><stitle>Neurol Sci</stitle><addtitle>Neurol Sci</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>43</volume><issue>6</issue><spage>3489</spage><epage>3496</epage><pages>3489-3496</pages><issn>1590-1874</issn><eissn>1590-3478</eissn><abstract>Background COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE. Methods This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events. Results We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination ( p  = 0.46). Conclusions The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35224704</pmid><doi>10.1007/s10072-022-05956-6</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-0651-7276</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1590-1874
ispartof Neurological sciences, 2022-06, Vol.43 (6), p.3489-3496
issn 1590-1874
1590-3478
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8882374
source Springer Nature
subjects Adverse events
Convulsions & seizures
Coronaviruses
Covid-19
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
Cross-Sectional Studies
Epilepsy
Humans
Immunization
Medicine
Medicine & Public Health
Neurology
Neuroradiology
Neurosciences
Neurosurgery
Pandemics
Patients
Psychiatry
SARS-CoV-2
Seizures
Seizures - epidemiology
Vaccines
title Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T23%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20COVID-19%20vaccines%20safe%20for%20people%20with%20epilepsy?%20A%20cross-sectional%20study&rft.jtitle=Neurological%20sciences&rft.au=%C3%96zdemir,%20H%C3%BCseyin%20Nezih&rft.date=2022-06-01&rft.volume=43&rft.issue=6&rft.spage=3489&rft.epage=3496&rft.pages=3489-3496&rft.issn=1590-1874&rft.eissn=1590-3478&rft_id=info:doi/10.1007/s10072-022-05956-6&rft_dat=%3Cproquest_pubme%3E2666705635%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2666705635&rft_id=info:pmid/35224704&rfr_iscdi=true